* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download New Concepts of the Neuroendocrine Regulation of Gonadotropin
Recurrent neural network wikipedia , lookup
Synaptic gating wikipedia , lookup
Nervous system network models wikipedia , lookup
Axon guidance wikipedia , lookup
Neuromuscular junction wikipedia , lookup
Neural modeling fields wikipedia , lookup
Multielectrode array wikipedia , lookup
Neurotransmitter wikipedia , lookup
NMDA receptor wikipedia , lookup
Synaptogenesis wikipedia , lookup
Neural engineering wikipedia , lookup
Optogenetics wikipedia , lookup
Metastability in the brain wikipedia , lookup
Circumventricular organs wikipedia , lookup
Channelrhodopsin wikipedia , lookup
Development of the nervous system wikipedia , lookup
Stimulus (physiology) wikipedia , lookup
Molecular neuroscience wikipedia , lookup
Endocannabinoid system wikipedia , lookup
Signal transduction wikipedia , lookup
BIOLOGY OF REPRODUCTION 56, 293-302 (1997) New Concepts of the Neuroendocrine Regulation of Gonadotropin Surges in Rats Jon E. Levine' Department of Neurobiology & Physiology, Northwestern University, Evanston, Illinois 60208 ABSTRACT In species that ovulate spontaneously, two key events mediate the stimulation of preovulatory gonadotropin surges: 1) neurosecretion of a preovulatory LHRH surge and 2) an acute increase in responsiveness of the pituitary gland to the LHRH neurosecretory trigger. These processes, in turn, depend upon both the positive feedback actions of preovulatory estrogen secretions and specific neural signals for initiation of the surge. In female rats, the neural signals for the surge are principally derived from the 24-h neural clock, thereby limiting the timing of surges to the afternoon of proestrus. It remains unclear, however, how neural signals converge with endocrine signals (estrogen) inspecific brain cells and how their cellular integration leads to appropriate secretion of gonadotropin surges. Previous work has suggested that estrogen may exert its facilitatory actions by opening a neural "gate," thereby allowing transmission of the daily neural signal to surge-initiating neuronal groups. How may estrogen act to render a neural pathway patent? A conventional view holds that steroid hormones can exert permissive effects on signaling efficacy by modulating neurotransmitter receptor expression, intracellular second messenger production, and protein kinase activity. However, recent evidence has suggested that estrogen may also have the capacity to permit cross-talk between neurotransmitter signaling pathways and parallel transcriptional regulatory pathways. The progesterone receptor isan estrogen-inducible transcription factor that has been shown to be transactivated-even in the absence of its cognate ligandafter stimulation of neurotransmitter receptors coupled to adenylate cyclase stimulation. Thus, the convergence of neural and endocrine signals for the stimulation of gonadotropin surges could occur at the level of the progesterone receptor: estrogen may stimulate expression of progesterone receptors, which in turn may be initially transactivated by synaptic signals. Activated progesterone receptors may thereafter regulate transcription of target genes that control transmitter synthesis and release in neural circuitries governing LHRH gene expression and/or pulsatile LHRH release. An analogous mechanism may operate in pituitary gonadotrophs, in which ligand-independent transactivation of progesterone receptors mediates integration of neurosecretory and estrogen positive feedback signals, leading to increased pituitary responsiveness to LHRH. It is proposed that the "seeding" of specific neuronal groups and pituitary gonadotrophs with progesterone receptors, and perhaps other inducible transcription factors, comprises an important basis of estrogen's permissive role in the stimulation of gonadotropin surges. The validity of this integrative model remains to be confirmed, as does its possible importance in generating gonadotropin surges in other species. INTRODUCTION Neuroendocrine systems have evolved to effectively register, transduce, and integrate neural and humoral information, and to take appropriate physiological actions based upon assessments of these incoming physiological signals. In almost every neuroendocrine system-including the re'Correspondence: Jon E. Levine, Department of Neurobiology & Physiology, 2153 N. Campus Dr., Evanston, IL 60208. FAX: (847) 491-5211; e-mail: [email protected] 293 productive axis-classic negative feedback signals predominate in the maintenance of homeostasis. The hypothalamicpituitary-gonadal axis, however, also features a unique positive feedback control system, which is responsible for delivering a robust surge of pituitary gonadotropins into the peripheral circulation. In spontaneous ovulators, it is this mid-cycle, preovulatory gonadotropin surge that stimulates the ovulatory process and has thus been a central focus of study since the earliest years of neuroendocrine research. The key neuroendocrine signals for stimulation of gonadotropin surges have been known for many decades, yet the cellular mechanisms that integrate these signals are still not well understood. It is clear that preovulatory estrogen secretions convey signals of ovarian readiness for ovulation; in rats and probably in other species, neural signals are also required to initiate the surge process at a specified time and under the appropriate physiological conditions. How are both of these necessary signals-one endocrine (estrogen) and one neural-integrated within neurons and pituitary cells to ultimately produce LH surges of physiological magnitude and timing? A revised model for the neuroendocrine stimulation of gonadotropin surges is discussed below as it may apply to the female rat. The model provides a plausible basis for neuroendocrine integrative mechanisms that mediate surge generation, and, it is hoped, represents a logical extension of concepts derived over many years of experimentation with female rats, as summarized below. BASIC PHYSIOLOGY OF GONADOTROPIN SURGES IN RATS Secretions of LH and FSH during the ovulatory cycle of the rat are maintained at low levels on estrus, metestrus, diestrus, and the morning of proestrus, principally through the negative feedback actions of gonadal steroids [1, 2] and protein hormones, such as inhibin [3]. Under the influence of a rising tide of estrogen secreted by the ripening follicle(s), a primary surge of both gonadotropins is released on the afternoon of proestrus, which triggers ovulation on the following morning of estrus. A prolonged, secondary phase of FSH secretion continues throughout the morning of estrus and most likely functions to recruit ovarian follicles for the subsequent cycle [4]. The secondary FSH surge has been studied extensively, and its neuroendocrine basis has been described elsewhere [5]. It is the positive feedback actions of estrogen, together with the daily signal generated by the 24-h neural clock [6], that function as the major determinants of the primary LH and FSH surges. Ovarian progesterone released just before or during the surge greatly amplifies surges [7] and prevents their recurrence during the same period on the next day [8]. It is generally held that there are two critically important, steroid-dependent processes that together mediate the LH surge-generating process: 1) hypothalamic neurosecretion of a preovulatory LHRH surge [9-11] and 2) a coordinate increase in pituitary responsiveness to this neurosecretory trigger [12]. 294 LEVINE HYPOTHALAMIC MECHANISMS LHRH Pulse Generator In virtually all physiological situations, secretions of LH and FSH are governed by the neurosecretion of LHRH. The LHRH decapeptide is released from neurovascular terminals in the median eminence and conveyed via the hypophysial portal vasculature to the anterior pituitary gland, where it binds to receptors on gonadotrophs and stimulates synthesis and secretion of LH and FSH. The LHRH release process is almost invariably pulsatile [10-14], and in virtually all female and male mammals studied, this pulsatile release pattern has been found to be critically important in sustaining gonadotropin secretion [14, 15]. The cellular mechanisms that govern the pulsatile LHRH release process, however, remain poorly understood. Electrophysiological correlates of pulse generator activity have been characterized using mediobasal hypothalamic, multi-unit recordings in monkeys [16], sheep [17], goats [18], and rats [19]. Although these studies have not allowed for microanatomical mapping of pulsing cells and/or circuitries, they have provided a functional definition of the "LHRH pulse generator": a set of neurons that periodically fire a highfrequency volley of action potentials, eventuating in the neurosecretion of a LHRH pulse into the hypophysial portal vessels. Beyond this definition, the electrophysiological studies have also underscored the existence of at least two important elements of the LHRH pulse-generating process-a pacemaker, and a mechanism for electrophysiological synchronization among neurosecretory cells. The simplest model for pulsatility holds that pacemaking activity occurs within LHRH neurons themselves and that the activities of "slave" LHRH neurons are entrained to the rhythm of a dominant pacemaker within the population. This idea is supported by the recent observations that LHRH release from immortalized GT1 cells [20] in culture is pulsatile [21, 22]. Pulsatile LHRH release from isolated guinea pig mediobasal hypothalamus [23] and rat preopticmediobasal hypothalamic tissues in vitro [24] have also been documented, and these findings, too, support the idea of intrinsic LHRH pulsatility, since LHRH perikarya in these species are contained within these respective tissues. Early observations in hypothalamic-deafferented rats, however, have been difficult to reconcile with the foregoing idea. In female rats, few if any LHRH perikarya are situated in mediobasal hypothalamic areas, yet complete anterior hypothalamic deafferentation does not eliminate pulsatile LH release [25]. This paradox remains unresolved, and explanations have included possibilities that 1) descending afferent LHRH tracts may escape section in deafferentation studies, 2) a remaining few LHRH neurons situated caudal to sections can assume pacemaking activity, or 3) pacemaking activity is a function of cells of some other neuronal phenotype, which stimulate LHRH pulses through synaptic contacts with LHRH processes in the median eminence. If true, the last possibility might explain the finding that pulse generator activity can be recorded at sites within the mediobasal hypothalamus but not at sites in the preoptic area of the rat [19]. It is also possible that pulsatile LHRH release occurs as an emergent property of the integrated activities of heterogeneous neuronal populations. That there may at least be an amplification of LHRH pulsatility by other neurotransmitter cell groups has been suggested by the demonstration of synchrony between LHRH pulse patterns and release profiles of other transmitters, such as nor- epinephrine [26], neuropeptide Y (NPY) [27], and gamma aminobutyric acid (GABA) [28]. Some mechanism must also operate to synchronize the pulsatile release activity among LHRH neurons. Again, the simplest scenario is one in which synchronicity is achieved through intercellular signaling via LHRH-LHRH synaptic contacts [29] or gap junctions [30]. Some LHRH immunopositive terminals have been demonstrated in apposition to LHRH perikarya [29], and recent evidence suggests that LHRH receptors are expressed in LHRH neurons [31]. Other work suggests that a volume transmission mechanism, perhaps involving nitric oxide, could mediate synchronization among LHRH neurons [32]. LHRH Surges Preovulatory LHRH surges have been identified in rats [9-11], sheep [33, 34], and monkeys [35]; and indirect measurements suggest that they may occur in women [36]. In rats, where the necessity of this neurosecretory trigger in stimulating LH surges is unambiguous, a proestrous surge of LHRH in this species appears to be composed of a 2-4-h increase in the overall amount of LHRH release [9-11]. What is the relationship, if any, between LHRH pulses and LHRH surges? There has not been general agreement whether LHRH surges represent an increase in some feature of LHRH pulsatility (e.g., amplitude or frequency) or an increase in release controlled by some nonpulsatile neurosecretory mechanism. One possibility is that signals for the two processes are conveyed along completely separate pathways; in this scenario, there are two populations of LHRH neurons, with each controlling only pulsatility or surge production. If this were indeed the case, then the secretion of LHRH would be elevated during the LHRH surge in a nonpulsatile manner or, at the very least, in the absence of any change in the features of baseline LHRH pulsatility. Alternatively, LHRH surges may occur as a result of a stimulation of LHRH pulse generator activity; thus, a surge signal would in this case be conveyed to pacemaker cells in the LHRH pulse generator neuronal population, and an overall change in a feature of LHRH pulsatility (e.g., increased LHRH pulse amplitude or frequency) would be manifest. In a third possible scenario, signals for surge initiation would be conveyed to only a subset of the pulse generator neuronal population, and not only to pacemaker cells. In such a case, a stimulatory signal would be superimposed upon only some portion of the pulsing neuronal populations. Thus, the likely pattern of LHRH release during the LHRH surge would consist of abrupt, transient, and irregular changes in the features of LHRH pulsatility, with an overall increase in the amount of LHRH released. Our own observations in proestrous rats favor the last possibility-that surge signals are superimposed upon the activities of a subset of pulsing neurons. Using microdialysis to monitor LHRH release patterns at 5-min intervals, and blood sampling through atrial catheters, we recently re-examined the changes that occur in LHRH pulsatility as the LHRH and LH surges proceed in proestrous or ovariectomized, steroid-primed rats [37]. As exemplified in Figure 1, the LHRH surge is characterized by acute increases in pulse amplitude and by transient increases in pulse frequency. Overall, the pattern appears to be much more irregular than those in nonsurging animals, with less regular interpulse intervals and more variable pulse amplitude. Thus, 295 GONADOTROPIN SURGES IN RATS A DAILY NEURONAL SIGNAL 7 LHRH PULSE GENERATOR 6 'a 5 E * 4 3 - 2 ESTROGEN 1 0 1200 1400 1600 1800 2000 Time of Day FIG. 1. Profile of LHRH release during a gonadotropin surge. Microdialysate samples were collected at 5-min intervals in an ovariectomized rat treated with estradiol benzoate (30 Ig) 48 h and progesterone (5 mg) 4 h before initiation of sampling. Dialysates were analyzed for LHRH content by LHRH RIA. Blood samples were obtained hourly via jugular catheter, and LH levels were determined by LH RIA. Increased LHRH pulse amplitude occurred in association with the rising phase of the LH surge. Circles, LHRH levels in microdialysates; triangles, LH levels in peripheral plasma. LHRH pulsatility clearly continues throughout the LHRH surge, and the amplitude and frequency of the pulses are increased-and more irregular-in association with the rising phase of the LH surge. These data are most compatible with the hypothesis that neural signals for initiation of the LHRH surge are conveyed to a subset of neurons that comprise the LHRH pulse generator (Fig. 2). Is there a subset of "surge" LHRH neurons within the LHRH pulse generator that may specifically function as targets for these surge signals? Lesion data indicate that the integrity of hypothalamic sites that include the antero-ventral periventricular nucleus (AVPV) and preoptic area is required for the elaboration of LH surges in rats. Approximately 30% of LHRH neurons, particularly those situated in these hypothalamic areas, appear to be activated during LHRH surges as suggested by analyses of c-fos expression in LHRH immunopositive neurons in proestrous rats [38]. Moreover, a 25% increase in the number of preoptic neurons expressing LHRH mRNA occurs in anticipation of the LHRH surge [39], similar to the apparent increase in the number of LHRH immunopositive neurons at this time [40]. It remains to be demonstrated that these subsets of neurons share specific anatomical or electrophysiological inputs that may convey surge-related signals. It is interesting to note that electrophysiological correlates of pulse generator activity are diminished during the generation of LH surges in rats [41], as they are in monkeys [42] and goats [43]. This diminishment does not appear to represent a desynchronization of the pulsatile activity of FIG. 2. Schematic diagram of physiological control of LHRH surges in female rats. A daily neuronal signal is generated by the neural clock. Under the permissive influence of estrogen, the neuronal signal is conveyed to a subset of neurons that comprise the LHRH pulse generator. This convergence of estrogen's permissive signals with neural signals for the surge leads to the stimulation of subcellular processes that mediate increased LHRH release on the afternoon of proestrus. It is not known whether all of the neurons that comprise the LHRH pulse generator are LHRH neurons or whether other neuronal phenotypes are also actively engaged in pulse generation. different units [41-43]. It is not clear how such a change in electrophysiological activity may be associated with the known increases (surges) in LHRH release during this period. It is possible that the apparent dissociation between electrophysiological events and LHRH neurosecretion reflects a much greater phenotypic heterogeneity among cellular components of a broader "pulse-generating apparatus" than was previously believed. Thus, some components of a central pulse-generating mechanism may direct release of LHRH, and some may not, and it may be the latter units that are suppressed during LHRH surge production. Alternatively, some acute alteration in cellular activity may occur at the level of the microelectrode recording, which may be upstream (at or closer to the perikarya) from the cellular locus at which pulse signals are conveyed to a given cell. It is hoped that this interesting paradox will soon be resolved. What Is the Daily Neuronal Signal? In their classic 1950 study, Everett and Sawyer [6] demonstrated that injection of barbiturates during an afternoon "critical period" in proestrous rats delays ovulation by 24 h. Their major conclusion-that a daily neural signal governs the release of the preovulatory gonadotropin surgehas been validated in numerous subsequent findings, such as the observation that sustained estrogen treatment of ovariectomized animals produces daily, afternoon LH surges [44]. The basic physiological control of LH surges in fe- 296 LEVINE male rats has thus been conceptualized as dependent upon two phenomena: 1) generation of a daily signal within the nervous system, probably by the circadian clock that is resident in the suprachiasmatic nucleus and 2) the positive feedback actions of estrogen, which permit the daily neuronal signal to be conveyed to neural circuits controlling LHRH release. This physiological control system for the surge effectively solves two major problems in the control of ovulation in rats: ovarian readiness and coordination with behavior. The dependence of the surge upon estrogen dictates that ovulation occurs only after sufficient maturation of ovarian follicles; the dependence of the surge on a circadian, neural signal restricts its occurrence to a specific circadian time. This restriction ensures that sexual behavior and ovulation both occur within the same window of time, and that both processes are initiated during the animal's maximal waking hours. Lesion experiments [45] and split-rhythm studies [46] clearly demonstrate that the daily neural signal for release of LHRH and LH surges is derived from the activity of the circadian clock. The microanatomical substrates of the daily neuronal signal, however, are obscure and will probably remain so until output pathways from the circadian clock are functionally defined. It appears unlikely that a single neurotransmitter cell group mediates transmission of the daily neuronal signal to the LHRH releasing system, given the sheer volume of pharmacological and transmitter effects on preovulatory surges that have been demonstrated. How Are Neural and Endocrine Signals Integrated in Neurons? The stimulation of LHRH surges occurs rapidly, suggesting that a stereotyped set of synaptic signals are the proximal cause of surge initiation. Since estrogen treatment (without progesterone) permits daily stimulation of LHRH release by these signals, it is reasonable to postulate that a major action of the steroid is to render patent the neural pathways that convey these signals. In the absence of estrogen stimulation, these neural gates remain closed. That estrogen acts in this manner is supported by observations that many neurotransmitter effects on LHRH release are maximal after animals are primed with the steroid (e.g., norepinephrine, NPY [47, 48]). Few estrogen receptors have been found in LHRH neurons in the rat [49], and thus the positive feedback effects of the steroid may be largely exerted via interneuronal networks that, in turn, control LHRH release. The neurotransmitter cell phenotypes in which estrogen may convey its positive feedback signals may include a variety of neuronal populations, each producing one or more amino acid, monoaminergic, or peptidergic transmitters. The strongest case for specific involvement of a given neurotransmitter cell group has been made for noradrenergic, GABA-ergic, glutaminergic, endorphinergic, and NPY-ergic neurons (see [50] for review). At the cellular level, it is conceivable that estrogen may confer synaptic patency by regulating expression or activity of one of several components of signal transduction pathways in a post-synaptic neuron, e.g., receptors, G-proteins, amplifying enzymes, second messengers, protein kinases, or protein kinase substrates. Indeed, in a variety of tissues the permissive actions of estrogen have been shown to be mediated in part by one or more of these mechanisms, one example being the estrogen-induced up-regulation of uterine alpha-adrenergic receptor, which mediates up-regulation of uterine contractile responses [51]. In brain, estrogen has been shown to exert some of its effects on sexual behavior through stimulation of oxytocin receptor gene expression [52]. Negative effects on coupling of -adrenergic receptors to G-proteins have also been demonstrated [53]. As yet, however, no effects of estrogen on the expression or activity of intracellular signaling molecules have been unequivocally demonstrated to be specifically involved in the initiation of LHRH surges. How else may estrogen act to open neural "gates?" One way that this might be conceptualized is that in the absence of estrogen, i.e. in the "closed" state, a molecular component of an alternative signaling pathway is either absent or inactive; estrogen functions to either supply or activate that molecule and thereby permits signaling traffic through a previously closed path. This differs from the foregoing possibilities in that a signaling pathway is opened de novo: signals follow a new pathway that branches off from the cell's conventional signaling pathway. This may permit more of an "all-or-none" gating system to operate, as opposed to a system that depends upon a graded increase in patency of the primary signaling pathway. It would also not require that a cell's conventional signaling pathways remain in a functionally depressed state at virtually all times except for the transient period following estrogen exposure. Which molecule(s) may function as estrogen-induced, intracellular links to pathways that mediate LHRH surge induction? Recent work in other neuroendocrine systems [54, 55] has demonstrated that the progesterone receptor may function in this capacity. Progesterone Receptors and Neuroendocrine Integration Like other members of the steroid receptor superfamily, progesterone receptors are intracellular, ligand-inducible transcription factors. Binding of ligand prompts a series of events, including alterations in interactions with molecular chaperones and dimerization of receptors, culminating in the binding of receptors with specific cis-acting elements of target genes. Two isoforms of the progesterone receptor, the B form and the N-terminally truncated A form, have been characterized, and the possibility that they mediate different activities in cell populations is under scrutiny. Progesterone binding sites and receptor immunoreactivity have been demonstrated in brain areas known to be important in the regulation of LHRH surges, particularly the AVPV [56, 57]. It is not known, however, whether one of the two receptor forms is expressed to a greater extent in the AVPV or figures more importantly in the production of LHRH surges. In many neuronal populations, including the AVPV, the expression of progesterone receptors is strongly dependent upon estrogen [58-61]. Treatment of estrogen-primed animals with progesterone greatly amplifies and temporally advances gonadotropin surges, and it is presumed that progesterone exerts these effects through estrogen-induced progesterone receptors in AVPV and other target neural loci. That progesterone receptor activation is critically important in the initiation of surges is reflected by the observation that pretreatment of proestrous rats with the progesterone receptor antagonist, RU-486, greatly attenuates LH surges (Fig. 3; [62]). Just before the initiation of normal preovulatory LH surges, however, very little ovarian and/or adrenal progesterone is secreted into the circulation [63-65]. It has remained puzzling, therefore, how progesterone receptor activation may play an important role in surge initiation, at a GONADOTROPIN SURGES IN RATS 297 12 T saline E 8 RU486/oil /l r I J 4 n-cci~a-/E--00 YIY- 0 1 To I 12 14 0 l 0 I · · 16 18 20 s\% 02 22 TIME (hrs) FIG. 3. Blockade of LH surges by RU-486 in proestrous rats. The type II1progesterone receptor antagonist RU-486 (squares), or oil vehicle (circles) was injected s.c. at 1200 h proestrus. Standard error bars omitted when smaller than corresponding symbols. time when circulating levels of the steroid have undergone either no change or an extremely modest rise. On the basis of recent findings in other neuroendocrine systems [54, 55], my colleagues and I have proposed a solution to this apparent paradox: that progesterone receptor transactivation does not initially occur as a consequence of hormone binding but instead results from the neural activation of intracellular second messenger systems that can transactivate the receptor in a ligand-independent manner. Thus, neural signals for the initiation of the LHRH surge, e.g., the daily neuronal signal, may directly stimulate the initial steps leading to surge production through progesterone receptor-dependent transcriptional regulation of target genes. Two signals for surge initiation are thereby effectively integrated at the level of the progesterone receptor: estrogen signals convey "permission" for stimulation of surges by virtue of their ability to induce progesterone receptors; neural signals for the appropriate "timing" of the surge are then conveyed through progesterone-independent activation of these estrogen-induced receptors. The neural stimulation of estrogen-induced progesterone receptors is proposed as the initial step in a cascade of cellular events leading to the LHRH surge. In this way, the estrogen's positive feedback signal and neural, circadian signals are integrated to produce LHRH surges of appropriate timing. There is now considerable evidence that ligand-independent activation of steroid receptors can occur in a biological context. Denner et al. [66] originally reported that protein kinase (PK) A could activate avian progesterone receptormediated transcription, even in the absence of steroid ligand. Subsequent work demonstrated that the neurotransmitter dopamine can stimulate progesterone-receptor-dependent activation of transcription in transfected CV1 cells in a ligand-independent manner [55]. The effects of dopamine appear to be mediated by PKA-dependent phosphorylation of the receptor and/or proteins that regulate DNA/ receptor binding [55]. Other examples of potential "crosstalk" between membrane- and steroid receptor-mediated pathways include epidermal growth factor-stimulated activation of the estrogen receptor [67] and activation of the vitamin D receptor by PKA [68]. In neuroendocrine systems, there is now compelling evidence for the physiological importance of ligand-independent activation of steroid receptors. In pituitary gonadotrophs, the LHRH self-prim- FIG. 4. Diagrammatic representation of model for the cellular integration of signals leading to the LHRH surge. See text for explanation. ing process has been shown to be mediated by ligand-independent activation of progesterone receptors; that is, LHRH-stimulated cAMP production stimulates PKA, thereby directly inducing progesterone receptor transactivation [54]. Similarly, neurotransmitters such as dopamine appear to facilitate sexual behavior through cAMP/PKA-mediated activation of progesterone receptors in central neurons [55]. A Revised Model for the Mid-Cycle LHRH Surge My colleagues and I have proposed a revised model of the neuroendocrine processes mediating LHRH surges, based upon the proposal that the progesterone receptor can function as a molecular site for integration of neural and endocrine signals. The essential components of LHRH surge generation are schematized in Figure 4, namely, the daily neuronal signal, estrogen positive feedback signals, afferent neuronal circuitries, and LHRH neurons. The daily neuronal signal is generated each afternoon, as indicated by the arrow at the top of each panel (Fig. 4, a-e). In the absence of a preovulatory estrogen surge (a), no progesterone receptors are expressed in afferents to LHRH neurons; hence, without available progesterone receptors, the daily neuronal signal is not coupled to the activation of the surge process. After preovulatory estrogen secretion (b), the expression of progesterone receptors is stimulated in afferent neurons, and thus (c) the daily neuronal signal, conveyed via the binding of neurotransmitters to their receptors and production of intracellular second messengers such as cAMP, results in ligand-independent transactivation of progesterone receptors. Once transactivated, these receptors induce transcriptional changes in target genes, leading to increased synthesis and/or release rate of transmitter from afferent neurons. These neural signals are conveyed through afferent circuitries to the LHRH neuron, evoking increased synthesis and/or release of LHRH, 298 LEVINE which comprises the LHRH surge. The LHRH surge triggers the LH surge (d), which stimulates ovulation and secretion of ovarian progesterone. The newly secreted progesterone [65] binds to remaining, unoccupied progesterone receptors, and their additional transactivation leads to further amplification of LHRH surges (e). With the binding and transactivation of progesterone receptors, they are down-regulated [69], resulting in a lack of progesterone receptor activation by the daily neuronal signal on the next day. Several experimental observations on the origin of LHRH surges may be more clearly explained by this model. The ability of the progesterone antagonist RU-486 to almost completely block preovulatory LH surges may now be understood as an ability of the drug to block progesterone receptor-mediated transcriptional regulation after neural (ligand-independent) activation of the progesterone receptors. The ability of progesterone to amplify estrogen-induced LH surges and to prevent their reoccurrence on successive days may also be explained more fully: in the absence of progesterone, estrogen alone evokes small LHRH surges, which most likely reflect only the neural activation of progesterone receptors, without additional activation of progesterone receptors by progesterone. Without additional receptor occupancy-and presumably down-regulationsufficient progesterone receptors remain to permit generation of surges on successive days. If progesterone is secreted (or exogenous progesterone administered), then many more progesterone receptors are occupied, and the amplification of the surge occurs, as does the full downregulation of progesterone receptors [69]. The latter process renders neurons incapable of further transmission of the daily neuronal signal on the following day. What other evidence is necessary to provide support for this model? My colleagues and I have recently provided two pieces of evidence that favor this hypothesis. In rats that were ovariectomized on the afternoon of diestrus II, estrogen treatments were given to stimulate LH surges on the subsequent day. In these animals, treatment with RU-486 was found to greatly attenuate the LH surges [70], presumably because of the blockade of the binding of transactivated progesterone receptors to DNA. The same phenomenon was also seen in ovariectomized and adrenalectomized rats, in which progesterone secretion is presumably nonexistent. Thus, even in the absence of progesterone as a ligand, progesterone receptors appear to be activated by neural signals as a requisite component of the surge-generating process. In a second study, progesterone receptor synthesis was blocked by intraventricular application of progesterone receptor antisense oligonucleotides. Similar to our observations with RU-486, the antisense, but not missense oligonucleotides, greatly attenuated LH surge production in the absence of circulating progesterone [71]. In other studies, we are currently attempting to determine whether estrogen is likewise ineffective in stimulating preovulatory gonadotropin surges in transgenic animals lacking a functional progesterone receptor gene [72]. Beyond these studies, proof of the validity of the proposed model will require development of in vivo cellular markers of progesterone receptor activation. Moreover, if the model is found to be valid, then important questions remain: Is the progesterone receptor the only estrogen-induced transcription factor that serves as a locus for integration of neural and endocrine signals for the surge? That RU-486 blocks only about half of the estrogen-induced LH surge suggests that other factors may also function as such. Is ligand-in- dependent activation of progesterone receptors as important in the production of LHRH surges in other species? In animals in which the LH surge appears to be less dependent upon a circadian signal, the integration of ovarian and daily neuronal signals may not figure as importantly. It is possible, however, that other neural command signals, not reflecting input from the circadian clock, may instead converge with ovarian steroid negative feedback at the progesterone receptor in other species. What is the adaptive significance of this integrative mechanism in rats? The integration of a permissive ovarian signal (estrogen) with a timed, neural signal effectively solves two major problems in the control of ovulation. The permissive effects of estrogen ensure that LHRH surges occur only after sufficient maturation of the dominant follicle, since it is only a ripened follicle that provides a sufficient estrogen surge. Without neural signals, however, estrogen alone does not initiate the surge; it merely provides patency to neural pathways that subserve commands for surge generation. The second adaptive advantage is derived from the neural specification of the timing of the surge. The dependence of surge initiation on an afternoon signal ensures that the consequence of the surge, i.e., ovulation, occurs coincidentally with maximal sexual receptivity and during a circadian time of maximal wakefulness. Obviously, the greatest temporal overlap in the timing of behavioral heat, wakefulness, and ovulation provides the greatest chance for conception and successful reproduction. PITUITARY MECHANISMS The preovulatory gonadotropin surge depends also upon the regulation of responsiveness by pituitary gonadotrophs to the LHRH trigger. Again, both estrogen and neural signals are integrated to coordinate this process. Before the release of the preovulatory LHRH surge, a massive, 50-fold increase in pituitary responsiveness to LHRH occurs in two phases. The first phase occurs gradually during the 48 h before the surge and depends primarily upon preovulatory estrogen secretion. An abrupt, 10-fold increase in responsiveness then occurs just before, and during initiation of, the LH surge. The latter phase may be mediated by pituitary actions of ovarian [73] or adrenal [63] progesterone, LHRH "self-priming" [74, 75], and the actions of additional neurohormonal "responsiveness factors," such as NPY [76-78], galanin [79], and endothelin [80]. The delivery of the LHRH surge to this exquisitely sensitized pituitary gland results in stimulation of a preovulatory LH surge that is 10- to 100-fold over baseline levels, and perhaps 5- to 10-fold higher than necessary to trigger ovulation [81]. This release of excess gonadotropin during the ovulatory surge may provide insurance that the surge effectively triggers this critically important reproductive event. The mechanisms by which estrogen may increase pituitary responsiveness have not been fully resolved but clearly involve both direct (pituitary) and indirect (hypothalamic) actions of the steroid. Estrogen's direct stimulatory effects in pituitary gonadotrophs may be exerted at numerous points in the subcellular signaling pathways that lead to gonadotropin release. The stimulation of LHRH receptors by the decapeptide is now known to result in activation of several intracellular signaling pathways, which in turn direct both early and delayed events underlying secretion of gonadotropins. The rapid events, such as Ca 2+ entry and exocytosis, may be mediated in part via posttranslational protein modifications. Delayed responses, such as gonado- GONADOTROPIN SURGES IN RATS tropin subunit gene expression, are probably mediated by alterations in transcription and/or translation, as well as posttranslational modifications of proteins that participate in signaling. It is likely that the priming of pituitary gonadotrophs by estrogen is mediated by effects of the steroid on characteristics of both of these types of responses, including changes in gonadotropin subunit biosynthesis [82, 83], amplification of the releasable LH pool (e.g., margination of gonadotropin secretory granules) [84], and stimulation of LHRH receptor synthesis [85, 86]. Indirectly, estrogen may alter pituitary responsiveness by inducing changes in LHRH and other neurohormone secretions, which in turn may regulate LH biosynthesis, LH secretion, or LHRH signal transduction, as discussed below. Interestingly, the integration of estrogen-induced neurohormonal signals with estrogen's direct effects on the pituitary gland may be mediated by ligand-independent activation of progesterone receptors, paralleling the mechanism proposed for central integrative processes leading to LHRH surges. LHRH Self-Priming The LHRH self-priming mechanism is defined as an enhanced secretory response by gonadotrophs to the second of a pair of equal LHRH stimuli [74, 75]. The phenomenon is estrogen-dependent, requires protein synthesis, and does not depend upon de novo LHRH receptor synthesis [74, 75]. The process appears to be mediated, at least in part, via the stimulation of cAMP production in gonadotrophs [87]. It has been proposed that the self-priming mechanism functions as an integral part of the preovulatory priming of pituitary gonadotrophs to the decapeptide. Recent work has shown that the progesterone receptor may function as a critically important component of the self-priming process, in that cross-talk may occur between cAMP/PKA and unliganded progesterone receptors [88]. Thus, LHRH may bind receptors coupled to adenylate cyclase via Gs, and stimulate cAMP in gonadotrophs; this may stimulate, in a ligand-independent manner, transactivation of progesterone receptors, which in turn regulate expression of target genes controlling gonadotropin release. The LHRH self-priming mechanism may essentially represent a pituitary version of the neuronal mechanism that is proposed to integrate ovarian and neural signals for the surge in central neurons. Similar to the proposed neuronal mechanism, estrogen may permit the process to take place by "seeding" pituitary gonadotrophs with progesterone receptors. Neurohormonal signals (LHRH pulses) thereafter initiate the process at an appropriate time-just before the surge-to increase pituitary responsiveness to LHRH. Like the central integrative process, this mechanism provides two major adaptive advantages for the animal: 1) it depends upon the preovulatory estrogen surge and therefore occurs only after presumptive follicular maturation, and 2) it is appropriately timed by neural signals, so as to amplify surges in the afternoon hours just preceding behavioral heat. The latter adds insurance to the likelihood that ovulation will take place when the animal is sexually receptive. Other Responsiveness Factors: NPY Recent studies have confirmed that the nervous system may produce additional neurohormones-apart from the LHRH decapeptide-that play critically important roles in regulating pituitary responsiveness to LHRH. In the rat, the strongest case has been made for the 36-amino acid peptide NPY, which is produced in greatest amounts in arcuate nu- 299 cleus neurons and released at synaptic sites throughout the basal forebrain. The actions of NPY on LHRH release during the initiation of LHRH surges has been clearly documented [89, 90]. Importantly, NPY is also released at neurovascular terminals in the median eminence [91] and can modulate gonadotropin secretions [76-78]. There is now a substantial body of evidence demonstrating that NPY gene expression [92, 93] and release [91] are increased before, and in concert with, the stimulation of LH surges. Peripheral immunoneutralization [94] and NPY receptor blockade [95] results in severe attenuation of LH surges, confirming the obligatory role of this putative responsiveness factor in the stimulation of physiologically proportioned LH surges. The peptide has been shown to potentiate the actions of LHRH in vitro [76, 96] and in vivo [77, 79], and, interestingly, it does not exert profound actions on its own [77]. Thus, NPY appears to subserve an important role as an amplifier of LHRH actions. The broader, physiological significance of these actions is not clear, but NPY facilitation may represent a permissive action by the nervous system that amplifies the surge under conditions in which other actions of NPY induce compatible homeostatic conditions for reproduction, i.e., increased feeding [97] or anxiolysis [98]. How may responsiveness factors such as NPY exert their effects on gonadotrophs? The effects of NPY are probably mediated via stimulation of NPY Y1 receptors [99] in gonadotrophs. NPY actions are estrogen-dependent and can be blocked by pretreatment with RU-486 [100]. It is possible, then, that NPY may exert its effects by stimulating the subcellular pathways that mediate LHRH self-priming. However, NPY effects cannot be demonstrated on the morning of proestrus, when LHRH self-priming is evident [100]. Moreover, NPY receptors have almost always been shown to be coupled negatively to adenylyl cyclase activity, and not in the positive manner that would be predicted for ligand-independent activation of progesterone receptors. The facilitatory actions of NPY, and the steroid-dependency of these actions, thus remain to be characterized. One result of NPY actions on gonadotrophs is an increase in the number [101] or affinity [102] of LHRH receptors. Since unmasking of cryptic LHRH receptors has been suggested to be mediated by PKC [103], it is conceivable that the NPY receptor stimulation leads to phosphoinositiol hydrolysis and PKC activation [104], and hence, augmentation of LHRH binding site density. In addition to NPY, there are probably other responsiveness factors that are secreted into the hypophysial portal vasculature and can modify responsiveness of the gland to LHRH. The peptide galanin, made in both hypothalamus and anterior pituitary gland, may exert similar actions during the generation of preovulatory surges [79]. The importance of NPY, galanin, and other neuropeptide factors in modulating pituitary responsiveness remains to be more fully explored in other species, including humans. EXTRINSIC CONTROL OF OVULATORY CYCLICITY A variety of physiological and exteroceptive variables exert profound influences over both the hypothalamic and pituitary components of gonadotropin surge generation. Neuronal systems that convey photoperiodic, stress/immune-related, appetitive, or sensory information have been shown to regulate surge production, yet the cellular mechanisms mediating these effects remain obscure. It is not known, for example, whether each of these regulatory in- 300 LEVINE fluences is exerted on cyclicity upstream or downstream from sites at which steroid and neural signals are integrated. Indeed, the latter cell groups remain uncharacterized; while immunocytochemical studies have revealed cell groups in which estrogen acts to induce progesterone receptors, it has not yet been determined which of these cells receives a daily neuronal signal. Even more important, it remains to be shown that ligand-independent activation of progesterone receptors occurs in these cells and that this leads to events that produce LHRH surges. ACKNOWLEDGMENTS FUTURE DIRECTIONS: MOLECULAR PHYSIOLOGY OF GONADOTROPIN SURGES 1. Gallo RV. Pulsatile LH release during periods of low-level LH secretion in the rat estrous cycle. Biol Reprod 1981; 24:771-779. 2. Leipheimer RE, Bona-Gallo A, Gallo RV. The influence of progesterone and estradiol on the acute changes in pulsatile luteinizing hormone release induced by ovariectomy on diestrus day 1 in the rat. Endocrinology 1984; 114:1605-1612. 3. Schwartz NB, Channing CP. Evidence for ovarian "inhibin" suppression of the secondary rise in serum follicle-stimulating hormone levels in proestrous rats by injection of porcine follicular fluid. Proc Natl Acad Sci USA 1977; 74:5721-5724. 4. McClintock JA, Schwartz NB. Changes in pituitary and plasma follicle stimulating hormone concentrations during the rat estrous cycle. Endocrinology 1968; 83:433-441. 5. Schwartz NB, Milette JJ, Cohen IR. Animal models which demonstrate divergence in secretion or storage of FSH and LH. In: Burger HD, de Kretser DM, Findlay JK (eds.), Inhibin: Non-Steroid Regulation of FSH Secretion. New York: Raven Press; 1995: 239-252. 6. Everett J, Sawyer CH. A 24h periodicity in the "LH release apparatus" of female rats, disclosed by barbiturate sedation. Endocrinology 1950; 46:198-216. 7. Everett JW. Progesterone and estrogen in the experimental control of ovulation time and other features of estrous cycle in the rat. Endocrinology 1948; 43:389-405. 8. Freeman MC, Dupke KC, Croteau CM. Extinction of the estrogeninduced daily signal for LH release in the rat: a role for the proestrous surge of progesterone. Endocrinology 1976; 99:223-229. 9. Sarkar DK, Chiappa SA, Fink G. Gonadotropin-releasing hormone surge in pro-oestrous rats. Nature 1976; 264:461-463. 10. Levine JE, Ramirez VD. Luteinizing hormone-releasing hormone release during the rat estrus cycle and after ovariectomy as estimated with push-pull cannulae. Endocrinology 1982; 111:1439-1448. 11. Park OK, Ramirez VD. Spontaneous changes in LHRH release during the rat estrous cycle as measured with repetitive push-pull perfusions of the pituitary gland in the same female rats. Neuroendocrinology 1989; 50:66-72. 12. Aiyer MS, Fink G. The role of sex steroid hormones in modulating the responsiveness of the anterior pituitary gland to luteinizing hormone releasing factor in the female rat. J Endocrinol 1974; 62:553572. 13. Levine JE, Duffy MT. Simultaneous measurement of luteinizing hormone releasing hormone, LH, and follicle-stimulating hormone release in intact and short-term castrate rats. Endocrinology 1988; 122: 2211-2221. 14. Levine JE, Bauer-Dantoin AC, Besecke LM, Conaghan LA, Legan SJ, Meredith JM, Strobl FJ, Urban JH, Vogelsong KM, Wolfe AM. Neuroendocrine regulation of luteinizing hormone pulse generator in the rat. Recent Prog Horm Res 1991; 47:97-153. 15. Knobil E. Neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 1980; 36:53-88. 16. Kaurman JM, Kesner JS, Wilson RC, Knobil E. Electrophysiological manifestation of luteinizing hormone-releasing hormone pulse generator activity in the rhesus monkey: influence of alpha-adrenergic and dopaminergic blocking agents. Endocrinology 1985; 116:1327-1333. 17. Thiery JC, Pelletier J. Multiunit activity in the anterior median eminence and adjacent areas of the hypothalamus of the ewe in relation to LH secretion. Neuroendocrinology 1981; 32:217-224. 18. Tanaka T, Mori Y, Hoshino K. Hypothalamic GnRH pulse generator activity during the estradiol-induced LH surge in ovariectomized goats. Neuroendocrinology 1992; 56:641-647. 19. Kimura F, Nishihara M, Hiruma H, Funabashi T Naloxone increases the frequency of electrical activity of the luteinizing hormone-releasing hormone (LHRH) pulse generator in long-term ovariectomized rats. Neuroendocrinology 1991; 53:92-96. 20. Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL, Weiner The neuroendocrine control of gonadotropin surges is a multi-layered, temporally organized process that includes a variety of seemingly redundant mechanisms. At the hypothalamic level, ovarian signals and directives from a neural clock are integrated within neurons to permit stimulation of processes leading to LHRH surges. In pituitary gonadotrophs, the actions of ovarian steroids are likewise integrated with neurosecretory signals to increase responsiveness to the LHRH surge. The net result is an appropriately timed, explosive surge of gonadotropins that triggers ovulation on the morning of estrus. My colleagues and I have proposed a central integrative mechanism that registers estrogen's positive feedback signals and thereafter permits command neural signals to be conveyed. The molecular basis of this proposed mechanism is the ligand-independent activation of progesterone receptors. A similar mechanism has already been proposed as the basis of estrogen's permissive actions with respect to the self-priming effects of LHRH in pituitary gonadotrophs. Confirmation of these hypotheses will probably require development of new in vivo models, such as transgenic animals in which the activation of progesterone receptors can be marked in individual cells in the brain. It also remains to be determined whether progesterone is but one of several transcription factors induced by estrogen and subsequently activated by neural signals. In 1983, it was demonstrated that few estrogen receptors are expressed in LHRH neurons. Since that time, intensive searches have been underway by numerous laboratories to identify the neuronal phenotypes that may convey positive feedback effects of estrogen. An argument can now be made that we are perhaps victims of our own success. Virtually every neurotransmitter imaginable has been shown to be either regulated by estrogen, or able to regulate LHRH release, or both. Countless regulatory schemes have been formulated accordingly, to describe how cells may interact to stimulate the LHRH and LH surges. It is arguable, however, whether the sum of the parts of these schemes has yielded a clearer picture of how the whole system operates. The urge to construct intricate circuitries that control preovulatory LHRH release, based upon supposedly uniform actions of various transmitter cells, has perhaps obscured an even more important issue: how does physiological integration of neural and endocrine signals take place at the molecular level, in any cell? When we are better armed with this knowledge, it may then be a less daunting task to consider which neuronal populations may serve in this capacity. The hypotheses proposed in this paper may ultimately be proven valid, partially valid, or untenable. At the very least, however, it is hoped that they provoke a significant change in the prevailing paradigm, namely, in how we conceptualize and experimentally approach the cellular basis of the preovulatory gonadotropin surge. This work was supported in part by NIH grants R01-HD20677, P01HD21921, and P30-HD28048. Many of the trainees who participated in the studies cited were supported by a Training Grant in Reproductive Biology from the National Institute for Child Health and Human Development, T32-HD07068. I am grateful to my colleague, Dr. Janice H. Urban, and to Patrick E. Chappell, Sarah M. Leupen, and Ming Xu for their help and advice in the writing of this review. REFERENCES GONADOTROPIN SURGES IN RATS 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. RI. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron 1990; 5:1-10. Martinez de la Escalera, G, Choi, ALH, Weiner RI. Generation and synchronization of gonadotropin releasing hormone (GnRH) pulses: intrinsic properties of the GTI-I GnRH neuronal cell line. Proc Natl Acad Sci USA 1992; 89:1852-1855. Wetsel WG, Vanenca MM, Mercanthaler I, Liposits Z, Lopez FJ, Weiner RI, Mellon P, Negro Vilar A. Intrinsic pulsatile secretory activity of immortalized, luteinizing hormone-releasing hormone-secreting neurons. Proc Natl Acad Sci USA 1992; 89:4149-4153. Giri M, Kaufman JM. Effects of long-term orchidectomy on in vitro pulsatile gonadotropin-releasing hormone release from the medial basal hypothalamus of the adult guinea pig. Endocrinology 1994; 134: 1621-1626. Dluzen DE, Ramirez VD. Transient changes in the in vitro activity of the luteinizing hormone-releasing hormone pulse generator after ovariectomy in rats. Endocrinology 1986; 118:1110-1113. Blake C, Sawyer CH. Effects of hypothalamic deafferentation on the pulsatile rhythm in plasma concentrations of luteinizing hormone in ovariectomized rats. Endocrinology 1974; 94:730-736. Teresawa E, Krook C, Hei DL, Gearing M, Schultz JJ, Davis GA. Norepinephrine is a possible neurotransmitter stimulating pulsatile release of luteinizing hormone-releasing hormone in the rhesus monkey. Endocrinology 1988; 123:1808-1816. Woller MJ, McDonald JK, Reboussin DM, Teresawa E. Neuropeptide Y is a neuromodulator of pulsatile luteinizing hormone-releasing hormone release in the gonadectomized rhesus monkey. Endocrinology 1992; 130:2333-2342. Jarry H, Leonhardt S, Wutke W A norepinephrine-dependent mechanism in the preoptic/anterior hypothalamic area but not in the mediobasal hypothalamus is involved in the regulation of the gonadotropin-releasing hormone pulse generator in ovariectomized rats. Neuroendocrinology 1990; 51:337-344. Leranth C, Segura LMG, Palkavits M, MacLusky NJ, Shanabrough M, Naftolin E The LHRH-containing neuronal network in the preoptic area of the rat: demonstration of LHRH-containing nerve terminals in synaptic contact with LHRH neurons. Brain Res 1985; 345:332-336. Liposits Z, Merchenthaler I, Wetsel WC, Reid JJ, Mellon PL, Weiner RI, Negro-Vilar A. Morphological characterization of immortalized hypothalamic neurons synthesizing luteinizing hormone-releasing hormone. Endocrinology 1991; 129:1575-1583. Cesnjaj M, Krsmanovic LZ, Catt KJ, Stojilkovic SS. Autocrine induction of c-fos expression in GT1-neuronal cells by gonadotropinreleasing hormone. Endocrinology 1993; 133:3042-3045. Mahachoklertwattana P, Black SM, Kaplan SL, Bristow JD, Grumbach MM. Nitric oxide synthesized by gonadotropin-releasing hormone neurons is a mediator of N-methyl-D-aspartate (NMDA)-induced GnRH secretion. Endocrinology 1994; 135:1709-1712. Moenter SM, Caraty A, Locatelli A, Karsh FJ. Pattern of gonadotropic-releasing hormone (GnRH) secretion leading up to ovulation in the ewe: existence of a preovulatory GnRH surge. Endocrinology 1991; 129:1175-1182. Moenter SM, Brand RC, Karsch FJ. Dynamics of gonadotropin-releasing hormone (GnRH) secretion during the GnRH surge: insights into the mechanism of GnRH surge induction. Endocrinology 1992; 130:2978-2984. Pau KY, Berria M, Hess DL, Spies HG. Preovulatory gonadotropinreleasing hormone surge in ovarian-intact rhesus macaques. Endocrinology 1993; 133:1650-1656. Elkind-Hirsch K, Ravnikar V, Tulchinsky D, Schiff I, Ryan KJ. Episodic secretory patterns of immunoreactive luteinizing hormone-releasing hormone (IR-LHRH) in the systemic circulation of normal women throughout the menstrual cycle. Fertil Steril 1984; 41:56-61. Chappell PE, Levine JE. LHRH pulse amplitude is increased during LH surges: a microdialysis study. In: 77th annual meeting of the Endocrine Society; 1995; Washington, DC. Abstract P3-339. Lee W-S, Smith S, Hoffman GE. Luteinizing hormone-releasing hormone neurons express fos protein during the proestrous surge of luteinizing hormone. Proc Natl Acad Sci USA 1990; 87:5163-5167. Porkka-Heiskanen T, Urban JH, Turek FW, Levine JE. Gene expression in a subpopulation of luteinizing hormone-releasing hormone (LHRH) neurons prior to preovulatory gonadotropin surges. J Neurosci 1994; 14:5548-5558. Hiatt ES, Brunetta PG, Seiler GR, Barney SA, Selles WD, Wooledge KH, King JC. Subgroups of luteinizing hormone-releasing hormone pericarya defined by computer analyses in the basal forebrain of intact female rats. Endocrinology 1992; 130:1030-1043. 301 41. Nishihara M, Sano A, Kimura E Cessation of the electrical activity of gonadotropin-releasing hormone pulse generator during the steroidinduced surge of luteinizing hormone in the rat. Neuroendocrinology 1994; 59:513-519. 42. O'Byrne KT, Thalabard JC, Grosser PM, Wilson RC, Williams CL, Chen MD, Ladendorf D, Hotchkiss J, Knobil E. Radiotelemetric monitoring of hypothalamic gonadotropin-releasing hormone pulse generator activity throughout the menstrual cycle of the rhesus monkey. Endocrinology 1991; 129:1207-1214. 43. Tanaka T Mori Y, Hoshino K. Hypothalamic GnRH pulse generator activity during the estradiol-induced LH surge in ovariectomized goats. Neuroendocrinology 1992; 56:641-647. 44. Legan SJ, Karsch FJ. A daily signal for the LH surge in the rat. Endocrinology 1975; 96:57-62. 45. Brown-Grant K, Raisman G. Abnormalities in reproductive function associated with the destruction of the suprachiasmatic nuclei in female rats. Proc R Soc Lond 1977; 198:279-296. 46. Swann JM, Turek FW. Multiple circadian oscillators regulate the timing of behavioral and endocrine rhythms in female golden hamsters. Science 1985; 228:898-900. 47. Condon TP, Handa RJ, Gorski RA, Sawyer CH, Whitmoyer DI. Ovarian steroid modulation of norepinephrine action on luteinizing hormone release. Neuroendocrinology 1986; 43:550-556. 48. Sabatino FD, Collins P, McDonald JK. Neuropeptide Y stimulation of LHRH secretion from the median eminence in vitro by estrogen dependent and extracellular Ca++-independent mechanisms. Endocrinology 1989; 124:2089-2098. 49. Shivers BD, Harlan RE, Morell JI, Pfaff DW. Absence of oestradiol concentration in cell nuclei of LHRH-immunoreactive neurons. Nature 1983; 304:345-349. 50. Kalra SP. Mandatory neuropeptide-steroid signaling for the preovulatory luteinizing hormone-releasing hormone discharge. Endocr Rev 1993; 14:507-538. 51. Hoffman BB, Lavin TN, Lefkowitz RJ, Ruffolo RR. Alpha adrenergic receptor subtypes in rabbit uterus: mediation of myometrial contraction and regulation by steroids. J Pharmacol Exp Ther 1981; 219:290295. 52. Coirini H, Johnson AE, McEwen BS. Estradiol modulation of oxytocin binding in ventromedial hypothalamic nucleus of male and female rats. Neuroendocrinology 1989; 50:193-198. 53. Ungar S, Makman MH, Morris SA, Etgen AL. Estrogen uncouples beta-adrenergic receptor from the stimulatory guanine-nucleotide binding protein in female rat hypothalamus. Endocrinology 1993; 133: 2828-2926. 54. Turgeon JL, Waring DW. Activation of the progesterone receptor by the gonadotropin-releasing hormone self-priming signaling pathway. Mol Endocrinol 1994; 8:860-869. 55. Power RE, Mani SK, Codina J, Conneely OM, O'Malley BW. Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 1991; 254:1636-1639. 56. Wiegand SJ, Terasawa, Bridson WE. Persistent estrus and blockade of progesterone-induced LH release follows lesions which do not damage the suprachiasmatic nucleus. Endocrinology 1978; 102:16451645. 57. Hagihara K, Hirata S, Osada T, Hirai M, Kato J. Distribution of cells containing progesterone receptor mRNA in the female rat di- and telencephalon: an in situ hybridization study. Mol Brain Res 1992; 14: 239-249. 58. MacLusky NJ, McEwen BS. Oestrogen modulates progestin receptor concentrations in some rat brain regions but not in others. Nature 1978; 274:276-278. 59. Parsons B, MacLusky NJ, Krey L, Pfaff DW, McEwen BS. The temporal relationship between estrogen-inducible progestin receptors in the female rat brain and the time course of estrogen activation of mating behavior. Endocrinology 1980; 107:774-779. 60. Romano GH, Krust A, Pfaff DW. Expression and estrogen regulation of progesterone receptor mRNA in neurons of the mediobasal hypothalamus: and in situ hybridization study. Mol Endocrinol 1989; 3: 1295-1300. 61. MacLusky NJ, McEwen BS. Progestin receptors in rat brain: distribution and properties of cytoplasmic progestin-binding sites. Endocrinology 1980; 106:192-202. 62. Bauer-Dantoin AC, Tabesh B, Norgle JR, Levine JE. RU486 administration blocks neuropeptide Y potentiation of luteinizing hormone (LH)-releasing hormone-induced LH surges in proestrous rats. Endocrinology 1993; 133:2418-2423. 63. Feder H, Brown-Grant K, Corker CS. Preovulatory progesterone, the 302 64. 65. 66. 67. 68. 69. 70. 71. 72. 73. 74. 75. 76. 77. 78. 79. 80. 81. 82. 83. LEVINE adrenal cortex, and the critical period for LH release in rats. J Endocrinol 1971; 50:29-39. Kalra SP, Kalra PS. Temporal relationships among circulating levels of estradiol, progesterone, and LH during the rat estrous cycle: effects of exogenous progesterone. Endocrinology 1974; 95:1711-1718. Smith MS, Freeman ME, Neill JD. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin, and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 1975; 96:219226. Denner LA, Weigel NL, Maxwell BL, Schrader WT, O'Malley BW Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 1990; 250:1740-1743. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 1993; 7:992-998. Huggenvik JI, Collard MW, Kim YW, Sharma RP. Modification of the retinoic acid signaling pathway by the catalytic subunit of protein kinase-A. Mol Endocrinol 1993; 7:543-550. Moguilewsky M, Raynaud JP The relevance of hypothalamic and hypophyseal progestin receptor regulation in the induction and inhibition of sexual behavior in the female rat. Endocrinology 1979; 105:516522. Chappell PE, Porkka-Heiskanen TJ, Levine JE. RU486 administration attenuates LH surges in the absence of endogenous progesterone. In: Society for Neuroscience 25th annual meeting; 1995; 21:1891 (Abstract 743.1). Chappell PE, Levine JE. Progesterone receptor antisense oligonucleotides block LH surges in ovariectomized, estrogen-primed rats. In: Society for Neuroscience 26th annual meeting; 1996; 22:958 (Abstract 379.7). Lydon JP, DeMao FJ, Funk CR, Mani SK, Hughes AR, Montgomery JR. CA, Shyamala G, Conneely OM, O'Malley BW. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes & Dev 1995; 9:2266-2278. Aiyer MS, Fink G. The role of sex steroids hormones in modulating the responsiveness of the anterior pituitary gland to luteinizing hormone releasing factor in the female rat. J Endocrinol 1974; 62:553572. Pickering AJ, Fink G. Priming effect of luteinizing hormone-releasing factor: in vitro and in vivo evidence consistent with its dependence upon protein and RNA synthesis. J Endocrinol 1976; 69:373-379. Waring DW, Turgeon. LHRH self-priming of gonadotropin secretion: time course of development. Am J Physiol 1983; 244:C410-418. Crowley WR, Hassid A, Kalra SP. Neuropeptide Y enhances the release of luteinizing hormone-induced by luteinizing hormone-releasing hormone. Endocrinology 1987; 120:941-945. Bauer-Dantoin AC, McDonald JK, Levine JE. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-induced LH surges in pentobarbital-blocked proestrous rats. Endocrinology 1991; 129: 402-408. Bauer-Dantoin AC, McDonald JK, Levine JE. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-induced LH secretion only under conditions leading to preovulatory LH surges. Endocrinology 1991; 131:2946-2952. Sahu A, Xu B, Kalra SP Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide. Endocrinology 1994; 134:529-536. Stojilkovic SS, Merelli F, Iida T, Krsmanovic LK, Catt KJ. Endothelin stimulation of cytosolic calcium and gonadotropin secretion in anterior pituitary cells. Science 1990; 248:1663-1666. Barraclough CA, Turgeon JL, Cramer OM. Neural correlates of adenohypophyseal LH release in rats. In: Stumpf WE, Grant LD (eds.), Anatomical Neuroendocrinology. Karger, Basel; 1975: 200-207. Shupnik MA, Gharib SD, Chin WW. Divergent effects of estradiol on gonadotropin gene transcription in pituitary fragments. Mol Endocrinol 1989; 3:474-479. Shupnik MA, Wienman AC, Notides AC, Chin WW. An upstream region of the rat LHB gene binds estrogen receptor and confers estrogen responsiveness. J Biol Chem 1989; 264:80-87. 84. Pickering AJ, Fink G. Variation in the size of the readily releasable pool of luteinizing hormone during the oestrous cycle of the rat. J Endocrinol 1979; 83:53-61. 85. Clayton RN, Catt KJ. GnRH receptors: characterization, physiological regulation and relationship to reproductive function. Endocr Rev 1981; 2:186-209. 86. Bauer-Dantoin AC, Hollenberg AN, Jameson JL. Dynamic regulation of gonadotropin-releasing hormone receptor mRNA levels in the anterior pituitary gland during the rat estrous cycle. Endocrinology 1993; 133:1911-1914. 87. Turgeon JL, Waring DW. cAMP augmentation of secretagogue-induced luteinizing hormone secretion. Am J Physiol 1986; 250:E62E68. 88. Waring DW, Turgeon JL. A pathway for luteinizing hormone releasing hormone self-potentiation: cross-talk with the progesterone receptor. Endocrinology 1992; 130:3275-3282. 89. Wehrenberg WB, Corder R, Galliard RC. A physiological role for neuropeptide Y in regulating the estrogen/progesterone-induced luteinizing hormone surge in ovariectomized rats. Neuroendocrinology 1989; 49:680-688. 90. Besecke LM, Levine JE. Acute increases in responsiveness of luteinizing hormone-releasing hormone nerve terminals to neuropeptide Y stimulation before the preovulatory LH surge. Endocrinology 1994; 135:63-66. 91. Watanabe H, Takabe K. Evidence that neuropeptide Y secretion in the median eminence increases prior to the luteinizing hormone surge in ovariectomized, steroid-primed rats: estimation by push-pull perfusion. Neurosci Lett 1992; 146:57-63. 92. Bauer-Dantoin AC, Urban JH, Levine JE. Neuropeptide Y gene expression in the arcuate nucleus is increased during preovulatory luteinizing hormone surges. Endocrinology 1992; 131:2953-2958. 93. Sahu A, Crowley WR, Kalra SP. Hypothalamic neuropeptide Y gene expression increases before the onset of the ovarian steroid induced luteinizing hormone surge. Endocrinology 1994; 134:1018-1022. 94. Sutton SW, Toyama TT, Otto S, Plotsky PM. Evidence that neuropeptide Y (NPY) released into the hypophysial portal circulation participates in priming gonadotropes to the effects of gonadotropin releasing hormone (GnRH). Endocrinology 1988; 123:1208-1210. 95. Besecke LM, Bauer-Dantoin AC, Wong DK, Levine JE. Blockade of preovulatory LH surges with a neuropeptide Y antagonist PYX2. Neuroscience 1994; 20 (suppl):942 (abstract 387.6). 96. Bauer-Dantoin AC, Knox KL, Schwartz NB, Levine JE. Estrous cycle-stage-dependent effects of neuropeptide Y on luteinizing hormone (LH)-releasing hormone-stimulated LH and follicle-stimulating hormone secretion from anterior pituitary fragments in vitro. Endocrinology 1993; 133:2413-2417. 97. Kalra SP, Clark JT, Sahu A, Dube MG, Kalra PS. Control of feeding and sexual behaviors by neuropeptide Y: physiological implications. Synapse 1988; 2:254. 98. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides. Science 1993; 259:528-530. 99. Leupen SL, Berg C, Levine JE. Pharmacological analysis of neuropeptide Y (NPY) receptors mediating NPY facilitation of LH surges. Neuroscience 1995; 21 (suppl):1885 (abstract 742.6). 100. Bauer-Dantoin AC, Tabesh B, Norgle JR, Levine JE. RU486 administration blocks neuropeptide Y potentiation of luteinizing hormone (LH)-releasing hormone-induced LH surges in proestrous rats. Endocrinology 1993; 133:2418-2423. 101. Parker SL, Kalra SP, Crowley WR. Neuropeptide Y modulates the binding of a gonadotropin-releasing hormone (GnRH) analog to anterior pituitary GnRH receptor sites. Endocrinology 1991; 128:2309. 102. Leblanc P, L'Heritier A, Rosolanjanahary R, Kordon C. Neuropeptide Y enhances LHRH binding to rat gonadotrophs in primary culture. Neuropeptides 1994; 26:87-92. 103. Leblanc P, Haour F L'Heritier, Mounier F, Kordon C. Temperature and PKC modulation of gonadotropin-releasing hormone receptors in pituitary cells from intact or castrarted male rats. J Neuroendocrinol 1990; 2:509-515. 104. Shigeri Y, Fujimoto M. Two different signal transductions of the neuropeptide Yl receptor in SK-N-MC cells. Biochem Biophys Res Commun 1992; 187:1565-1571.